Stem Cell Therapy Market Size Worth USD 92.08 Million by 2030 at 16.20% CAGR – Report by Market Research Future (MRFR)
New York, USA, March 06, 2023 (GLOBE NEWSWIRE) — Stem Cell Therapy Market Overview
According to a Comprehensive Research Report by Market Research Future (MRFR), “Stem Cell Therapy Market Information by Cell Source, Type, Application, End user and Region – Forecast till 2030”, the market is projected to reach USD 92.08 Million by 2030 at 16.20% CAGR during the forecast period 2022-2030.
Market Scope
Stem cell therapy refers to a procedure that uses stem cells to prevent or treat any disease or condition. The global market for stem cell therapy has registered enormous growth in the last few years. The market’s growth is primarily attributed to the increasing prevalence of chronic disorders across the globe. The global stem cell therapy market is likely to perceive an impressive growth rate over the current decade. The growing demand for fat & skin grafting procedures is a key driving force behind the market growth.
Stem cell therapy is a procedure involving the usage of a patient’s own adipose tissue to increase the fat volume in the area of reconstruction, thus promoting 3Dimentional reconstruction. Patients who have undergone trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or who have had an accident or injury need this therapy. Stem cell therapy is also used in cosmetic or plastic surgeries.
Over the past few years, increasing stem cell reconstructive surgeries led by the increasing number of accidents, limb amputation, and implants are fostering growth in the stem cell therapy market. Besides, the factors such as increasing geriatric populations, rising number of patients suffering from chronic diseases, and continuous technological development are escalating the stem cell market value globally.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/6422
Segmentation
The stem cell therapy market report is segmented into therapy types, cell sources, applications, end-users, and regions.
The cell source segment is sub-segmented into adipose tissues, bone marrow, neural, embryo/cord, IPSCs, and PPSCs.
The therapy type segment is sub-segmented into autologous and allogeneic.
The application segment is sub-segmented into cancer, musculoskeletal disorders, diabetes, gastrointestinal diseases, cardiovascular, and others.
The end user segment is sub-segmented into hospitals & clinics, ambulatory surgical centers, academic & research centers, and others.
The region segment is sub-segmented into Asia-Pacific, Americas, Europe, and rest-of-the-world.
Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=6422
Regional Analysis
North America dominates the global stem cell therapy market with the largest share globally. Factors such as the notable increase in incidences of stem cell surgeries and encouraging research & development activities in healthcare drive the market growth in the region. Additional factors, such as the increasing uptake of advanced technologies and high healthcare expenditures, substantiate the stem cell market size.
Owing to the rising demand for stem cell procedures, this market is expected to create a larger revenue pocket by 2030. The US, among other North American countries, accounts for the major stem cell market contributor due to the high expenditures on healthcare and the increasing demand for stem cell treatments.
Europe is another rapidly growing market for stem cell therapy globally. Advancements in medical technology and techniques in the region drive market growth. Additionally, the presence of a large patient population base alongside rising healthcare expenditures facilitates the regional market’s growth. Research & development support and funding from public & private sectors in this region are expected to fuel the stem cell therapy market revenues over the review period.
The Asia Pacific region is rapidly emerging as a lucrative market for stem cell therapy. Increasing incidents of stem cell surgeries and the development of related technologies, mainly in the countries such as India, China, and Japan, escalate the region’s market shares. Furthermore, the increasing adoption of newer technologies increases the demand for stem cell procedures. The APAC stem cell therapy market is projected to register a phenomenal CAGR during the forecast period.
Discover more research Reports on Healthcare Industry by Market Research Future:
Cell Therapy Market Research Report Information By Cell Type (Stem Cell, {Bone Marrow, Blood, Umbilical Cord-Derived, Adipose-Derived Stem Cell, and others [Placenta, and Nonspecific cells]}, and Non-stem Cell), By Therapy Type (Autologous, and Allogeneic), By Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and others), By End-User (Hospitals & Clinics, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, and the Rest of the World)—Forecast till 2030
CAR T Cell Therapy Market: Information By Target Antigen (CD19, CD22), By Application (Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia) and Region (US, Europe, China and Rest of World) – Forecast till 2027
Musculoskeletal System Disorders Market Research Report: By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis), Treatment (Biologics, Corticosteroids, Physical Therapy, Protein Therapy, Composite Grafts) and End User (Hospitals and Clinics, Ambulatory Surgical Centers) – Forecast to 2030
Related Links
- Cell Therapy Market
- CAR T Cell Therapy Market
- Musculoskeletal System Disorders Market
- Stem Cell Therapy Market
- 3D Cell Culture Market
- Stem Cell Assay Market
- Live Cell Imaging Market
- Cell Viability Assays Market
- Cell Surface Markers Market
- Stem Cell Manufacturing Market
- Cell Culture Media Market
- Cell Isolation Market
- Stem Cell Banking Market
- Cell Counting Market
- Cell Line Development Market
- Cell Cycle Analysis Market
- Stem Cell Reconstructive Market
- Circulating Tumor Cell Market
- Merkel Cell Carcinoma Treatment Market
- Spindle Cell Sarcoma Treatment Market
